COVID-19

Views & Analysis

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

Coronavirus pharma news roundup – 31/07/20

Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.

News

Gilead loses $3.3bn in Q2, blaming COVID-19 and cancer drugs...

Gilead has blamed a $3.3 billion loss in Q2 on its acquisition of immune-oncology company Forty Seven – but revenues are declining as the pandemic bit into sales of its hepatitis C drugs.

News

AstraZeneca beats expectations in Q2, while GSK struggles du...

AstraZeneca has beaten analysts’ expectations in its second quarter results, outshining its UK counterpart GlaxoSmithKline, which has been hit by disruption caused by the COVID-19 pandemic.

News

Trump reiterates hydroxychloroquine defense after son is ban...

Donald Trump has launched another defence of hydroxychloroquine as a treatment for COVID-19 which goes against prevailing medical advice.

Digital

The acceleration of pharma’s digital transformation

From this summer’s vantage point 2019 seems like it was at least a decade ago, such is the trainwreck that is 2020.

Podcasts

Novartis, company culture and COVID-19: the pharmaphorum pod...

Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face of company culture, now and in the future.

Coronavirus pharma news roundup – 31/07/20

Gilead loses $3.3bn in Q2, blaming COVID-19 and cancer drugs...

AstraZeneca beats expectations in Q2, while GSK struggles du...

Trump reiterates hydroxychloroquine defense after son is ban...

The acceleration of pharma’s digital transformation

Novartis, company culture and COVID-19: the pharmaphorum pod...

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks